zanamivir has been researched along with Body Weight in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abed, Y; Boivin, G; Pizzorno, A; Rhéaume, C | 1 |
Fukushi, M; Kubo, S; Kudo, K; Miyoshi-Akiyama, T; Yamamoto, K; Yamashita, M | 1 |
Crossman, L; Fenton, RJ; Gower, D; Morley, PJ; Owens, IJ; Parry, S; Wong, T | 1 |
Bush, K; Goloubeva, OG; Govorkova, EA; Leneva, IA; Webster, RG | 1 |
4 other study(ies) available for zanamivir and Body Weight
Article | Year |
---|---|
Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
Topics: Animals; Antiviral Agents; Body Weight; Disease Models, Animal; Drug Therapy, Combination; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Lung; Mice, Inbred C57BL; Orthomyxoviridae Infections; Oseltamivir; Survival Analysis; Treatment Outcome; Viral Load; Zanamivir | 2014 |
Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.
Topics: Animals; Body Weight; Carbon Dioxide; Chemokines; Dogs; Drug Therapy, Combination; Female; Guanidines; Influenza A Virus, H1N1 Subtype; Lung; Madin Darby Canine Kidney Cells; Mice; Mice, Inbred BALB C; Organ Size; Orthomyxoviridae Infections; Oxygen; Pressure; Pulmonary Surfactant-Associated Protein D; Pulmonary Surfactants; Pyrans; Sialic Acids; Survival Analysis; Viral Load; Zanamivir | 2012 |
Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Autoradiography; Body Weight; Female; Ferrets; Guanidines; Influenza A virus; Lung; Mice; Orthomyxoviridae Infections; Pyrans; Respiratory System; Sialic Acids; Zanamivir | 1999 |
Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
Topics: Acetamides; Acids, Carbocyclic; Animals; Antiviral Agents; Body Weight; Brain; Cyclopentanes; Disease Models, Animal; Dogs; Female; Guanidines; Influenza A virus; Influenza A Virus, H5N1 Subtype; Influenza A Virus, H9N2 Subtype; Lung; Mice; Mice, Inbred BALB C; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Pyrans; Sialic Acids; Treatment Outcome; Virus Replication; Zanamivir | 2001 |